Evidence map›Paper›PMID 42432038›Full record

ArticleScientific reports2026

Trade induced extinction risk footprints by European financial institutions.

Siwar Ortiz-Guzman, Julien Calas, Antoine Godin, Julie Maurin, Nicolas Roques, Daniel Kieling, Tatiana Novoa Fonseca

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Siwar Ortiz-GuzmanInstitute for Ecological Economics, Wirtschaftsuniversität Wien, Vienna, 1020, Austria. siwar.ortiz@wu.ac.at.ORCID https://orcid.org/0009-0009-7328-4028
Julien CalasAgence Française de Développement, 5 Rue Roland Barthes, 75012, Paris, France.
Antoine GodinAgence Française de Développement, 5 Rue Roland Barthes, 75012, Paris, France.
Julie MaurinAgence Française de Développement, 5 Rue Roland Barthes, 75012, Paris, France.
Nicolas RoquesBiotope, 25 Imp. Mousset, 75012, Paris, France.
Daniel KielingBiotope, 25 Imp. Mousset, 75012, Paris, France.
Tatiana Novoa FonsecaBiotope, 25 Imp. Mousset, 75012, Paris, France.

Funding

Austrian Science Fund 10.55776/EFP5
6 · The paper itself

Abstract

Biodiversity loss is increasingly recognized as a source of systemic financial risk. The financial sector enables economic activities that exert pressure on ecosystems, sometimes far from where capital is held, so institutions in one region can enable biodiversity loss elsewhere by financing seemingly harmless sectors with value-chain links to harmful activities. We establish a novel correspondence matrix linking 104 environmental pressures to 124 IUCN biodiversity threats, and combine it with the GLORIA input-output model to quantify species extinction-risk for 164 countries. Particulate matter, land-use change, and nitrogenous gases are the most damaging pressures, exerted mainly by agriculture, manufacturing, and construction. Seventy-four countries are net importers of extinction risk and twenty-three net exporters; all twelve European countries analysed are importers, with approximately 40% of their financial assets linked to extinction-risk sectors. Because these pressures are so embedded in production, a 1% reduction in the extinction-risk footprint propagates almost one-for-one through the economy: output falls by about 0.88% on average, while firms' capacity to service debt weakens as revenues drop but interest obligations hold fixed. This exposes how structurally dependent financial systems are on nature-harming activity, supporting efforts to disclose and reduce holdings of assets linked to biodiversity loss.

Identifiers

PMID42432038
PMCPMC13661235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.